Dry extracts of ginkgo leaves are considered promising drugs for improving age-related cognitive impairment. A study compared the phytochemical composition of fourteen medicines containing ginkgo that have been approved by German health authorities for this indication and revealed some considerable differences in the proportion of proanthocyanidins (PACs).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
- PHYTOTHERAPIE PRAXIS
Related Topics
You May Also Like
- Prostate cancer
High-resolution ultrasound could diagnose prostate cancer faster
- Chronic lung diseases
Sarcopenia and malnutrition in the context of pneumological rehabilitation
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Psychooncology
Communication as the key to therapy adherence
- From symptom to diagnosis
Lung carcinoma – Pancoast tumor
- Deep vein thrombosis
Outpatient or inpatient treatment?
- From symptom to diagnosis
Abdominal pain – Intraductal papillary mucinous neoplasia
- IBDmatters - Advanced Therapeutic Treatments